NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | DKK 309.1B2025 | +19.5% |
| Gross profit | DKK 250.3B2025 | +18.7% |
| Operating income | DKK 127.7B2025 | +18.7% |
| Net income | DKK 102.4B2025 | +19.4% |
| EPS | DKK 23.032025 | +5.0% |
| Free cash flow | DKK 59.0B2025 | +5.0% |